Author:
Rivera Christina G.,Zeuli John D.,Smith Bradley L.,Johnson Tanner M.,Bhatia Ramona,Otto Ashley O.,Temesgen Zelalem
Publisher
Springer Science and Business Media LLC
Reference109 articles.
1. Ending the HIV Epidemic in the U.S. | HRSA. Available from: https://www.hrsa.gov/ending-hiv-epidemic
2. US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV infection in the United States – 2021 Update, A Clinical Practice Guideline. 2021.
3. US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV infection in the United States – 2017 Update, A Clinical Practice Guideline. 2017.
4. Mayer KH, Molina JM, Thompson MA, Anderson PL, Mounzer KC, De Wet JJ, et al. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. Lancet. 2020;396(10246):239–54.
5. Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献